• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿德福韦与不同基因型 HBV 聚合酶的结合敏感性:分子建模、对接和动力学模拟研究。

Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.

机构信息

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.

出版信息

Acta Pharmacol Sin. 2013 Feb;34(2):319-28. doi: 10.1038/aps.2012.146. Epub 2012 Dec 3.

DOI:10.1038/aps.2012.146
PMID:23202802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4011611/
Abstract

AIM

To investigate the molecular mechanisms underlying the influence of DNA polymerase from different genotypes of hepatitis B virus (HBV) on the binding affinity of adefovir (ADV).

METHODS

Computational approaches, including homology modeling, docking, MD simulation and MM/PBSA free energy analyses were used.

RESULTS

Sequence analyses revealed that residue 238 near the binding pocket was not only a polymorphic site but also a genotype-specific site (His238 in genotype B; Asn238 in genotype C). The calculated binding free-energy supported the hypothesis that the polymerase from HBV genotype C was more sensitive to ADV than that from genotype B. By using MD simulation trajectory analysis, binding free energy decomposition and alanine scanning, some energy variation in the residues around the binding pocket was observed. Both the alanine mutations at residues 236 and 238 led to an increase of the energy difference between genotypes C and B (ΔΔG(C-B)), suggesting that these residues contributed to the genotype-associated antiviral variability with regard to the interaction with ADV.

CONCLUSION

The results support the hypothesis that the HBV genotype C polymerase is more sensitive to ADV than that from genotype B. Moreover, residue N236 and the polymorphic site 238 play important roles in contributing to the higher sensitivity of genotype C over B in the interaction with ADV.

摘要

目的

研究不同基因型乙型肝炎病毒(HBV)DNA 聚合酶对阿德福韦(ADV)结合亲和力的影响的分子机制。

方法

采用同源建模、对接、MD 模拟和 MM/PBSA 自由能分析等计算方法。

结果

序列分析表明,结合口袋附近的 238 号残基不仅是一个多态性位点,也是一个基因型特异性位点(基因型 B 中的 His238;基因型 C 中的 Asn238)。计算的结合自由能支持这样的假设,即来自 HBV 基因型 C 的聚合酶比来自基因型 B 的聚合酶对 ADV 更敏感。通过使用 MD 模拟轨迹分析、结合自由能分解和丙氨酸扫描,观察到结合口袋周围残基的一些能量变化。在残基 236 和 238 处的丙氨酸突变都导致了基因型 C 和 B 之间的能量差异(ΔΔG(C-B))增加,这表明这些残基对与 ADV 的相互作用中与基因型相关的抗病毒变异性有贡献。

结论

研究结果支持这样的假设,即 HBV 基因型 C 聚合酶比来自基因型 B 的聚合酶对 ADV 更敏感。此外,残基 N236 和多态性位点 238 在与 ADV 相互作用中对基因型 C 比 B 更高的敏感性中起重要作用。

相似文献

1
Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.阿德福韦与不同基因型 HBV 聚合酶的结合敏感性:分子建模、对接和动力学模拟研究。
Acta Pharmacol Sin. 2013 Feb;34(2):319-28. doi: 10.1038/aps.2012.146. Epub 2012 Dec 3.
2
Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance.阿德福韦、替诺福韦和恩替卡韦耐药机制:新型抗乙肝病毒药物(FMCA)如何克服耐药性的分子模拟研究
Curr Med Chem. 2015;22(34):3922-32. doi: 10.2174/0929867322666150904144802.
3
Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.阿德福韦酯治疗期间乙肝病毒载量及病毒基因组序列的演变
J Viral Hepat. 2004 Jan;11(1):74-83. doi: 10.1046/j.1365-2893.2003.00471.x.
4
HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.表达阿德福韦耐药突变的乙肝病毒临床分离株在B、C和D基因型中显示出相似的替诺福韦敏感性。
Liver Int. 2014 Aug;34(7):1025-32. doi: 10.1111/liv.12343. Epub 2013 Nov 20.
5
Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).采用INNO-LiPA HBV DR线性探针检测法(第2版)检测慢性乙型肝炎病毒感染患者样本中与阿德福韦酯耐药相关的rtN236T和rtA181V/T突变。
J Clin Microbiol. 2006 Jun;44(6):1994-7. doi: 10.1128/JCM.02477-05.
6
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.乙型肝炎病毒聚合酶基因的基因型特异性突变与口服抗病毒治疗耐药相关。
Antiviral Res. 2012 Dec;96(3):422-9. doi: 10.1016/j.antiviral.2012.09.014. Epub 2012 Sep 28.
7
Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients.从大量乙肝病毒感染患者队列中筛查和鉴定一种新型的与阿德福韦酯耐药相关的乙肝病毒突变,rtN236V。
Antivir Ther. 2014;19(6):551-8. doi: 10.3851/IMP2775. Epub 2014 Apr 8.
8
[Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].[慢性乙型肝炎和丙型肝炎患者的基因型分布及乙肝病例耐药模式调查]
Mikrobiyol Bul. 2010 Apr;44(2):237-43.
9
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.拉米夫定耐药乙型肝炎病毒对阿德福韦和替诺福韦的体外敏感性
Antivir Ther. 2004 Jun;9(3):353-63.
10
[Clinical analysis of hepatitis B virus mutations related to adefovir dipivoxil among patients with chronic hepatitis B virus infection in eastern Zhejiang province].[浙江省东部慢性乙型肝炎病毒感染患者中与阿德福韦酯相关的乙型肝炎病毒突变的临床分析]
Zhonghua Yi Xue Za Zhi. 2012 Jul 17;92(27):1878-81.

引用本文的文献

1
Small Molecule Drugs Targeting Viral Polymerases.靶向病毒聚合酶的小分子药物
Pharmaceuticals (Basel). 2024 May 20;17(5):661. doi: 10.3390/ph17050661.
2
Conformation and dynamics of the C-terminal region in human phosphoglycerate mutase 1.人磷酸甘油酸变位酶 1 的 C 端区域的构象和动力学。
Acta Pharmacol Sin. 2017 Dec;38(12):1673-1682. doi: 10.1038/aps.2017.37. Epub 2017 Jul 27.
3
Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis.通过计算分析探索CK2铰链区亚口袋在与三环喹诺酮类似物结合中的关键作用。
Molecules. 2017 May 19;22(5):840. doi: 10.3390/molecules22050840.
4
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.乙型肝炎病毒聚合酶rt269位点的替换是一种与多药耐药相关的补偿性突变。
PLoS One. 2015 Aug 31;10(8):e0136728. doi: 10.1371/journal.pone.0136728. eCollection 2015.
5
Structure-based ensemble-QSAR model: a novel approach to the study of the EGFR tyrosine kinase and its inhibitors.基于结构的集合定量构效关系模型:研究表皮生长因子受体酪氨酸激酶及其抑制剂的新方法。
Acta Pharmacol Sin. 2014 Feb;35(2):301-10. doi: 10.1038/aps.2013.148. Epub 2013 Dec 16.

本文引用的文献

1
Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.在中国一家医院中,核苷(酸)类似物初治与经治慢性乙型肝炎患者的 HBV 逆转录酶区潜在抗病毒耐药突变谱的差异。
J Med Virol. 2012 Feb;84(2):207-16. doi: 10.1002/jmv.23182.
2
Is there any value to hepatitis B virus genotype analysis?乙型肝炎病毒基因型分析有什么价值吗?
Curr Gastroenterol Rep. 2012 Feb;14(1):37-46. doi: 10.1007/s11894-011-0233-5.
3
An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor.一种优化的 MM/PBSA 虚拟筛选方法在 HIV-1 gp41 融合肽抑制剂中的应用。
Proteins. 2011 Nov;79(11):3221-35. doi: 10.1002/prot.23158. Epub 2011 Aug 30.
4
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.拉米夫定联合阿德福韦酯与恩替卡韦单药治疗拉米夫定耐药慢性乙型肝炎:系统评价和荟萃分析。
Virol J. 2011 Aug 8;8:393. doi: 10.1186/1743-422X-8-393.
5
Molecular dynamics simulation reveals structural and thermodynamic features of kinase activation by cancer mutations within the epidermal growth factor receptor.分子动力学模拟揭示了表皮生长因子受体中癌症突变引起的激酶激活的结构和热力学特征。
J Comput Chem. 2011 Oct;32(13):2843-52. doi: 10.1002/jcc.21866. Epub 2011 Jun 30.
6
Genotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang, China.在中国沈阳,通过 HBV DNA 聚合酶基因的片段进行乙型肝炎病毒基因分型。
Virol J. 2011 Jun 22;8:315. doi: 10.1186/1743-422X-8-315.
7
Computational determination of binding structures and free energies of phosphodiesterase-2 with benzo[1,4]diazepin-2-one derivatives.计算确定磷酸二酯酶-2 与苯并[1,4]二氮杂卓-2-酮衍生物的结合结构和自由能。
J Phys Chem B. 2010 Dec 9;114(48):16020-8. doi: 10.1021/jp1086416. Epub 2010 Nov 15.
8
Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.乙型肝炎病毒(HBV)亚基因型 C2 和 B2 在拉米夫定和阿德福韦耐药相关的突变模式方面存在差异,这与中国 HBV 感染患者有关。
J Clin Microbiol. 2010 Dec;48(12):4363-9. doi: 10.1128/JCM.01518-10. Epub 2010 Sep 29.
9
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.乙型肝炎病毒逆转录酶序列变异数据库,用于序列分析和突变发现。
Antiviral Res. 2010 Dec;88(3):269-75. doi: 10.1016/j.antiviral.2010.09.012. Epub 2010 Sep 25.
10
Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.用 3D-QSAR、分子对接和分子动力学研究苯并噻二嗪衍生物作为丙型肝炎病毒 NS5B 聚合酶抑制剂。
Curr Med Chem. 2010;17(25):2788-803. doi: 10.2174/092986710791859298.